Literature DB >> 28668972

A New SERPINA-1 Missense Mutation Associated with Alpha-1 Antitrypsin Deficiency and Bronchiectasis.

G E Carpagnano1, R Santacroce2, G A Palmiotti3, A Leccese2, E Giuffreda1, M Margaglione2, M P Foschino Barbaro1, S Aliberti4, D Lacedonia1.   

Abstract

Alpha-1-antitrypsin deficiency (AATD) is a genetic condition caused by SERPINA1 mutations, which culminates into lower protease inhibitor activity in the serum and predisposes to emphysema. Clinical manifestations of AATD are often associated to ZZ (p.Glu342Lys) and SZ (p.Glu264Val) genotypes and less frequently to rare deficiency or null alleles in heterozygous and homozygous states. We report a case of a 52-year-old woman with bronchiectasis without other potential causes other than an electrophoresis that showed a decrease of alpha-1 globin band and AAT levels below the normal value (78 mg/dl; v.n. 90-200 mg/dl). No S or Z mutation was identified, but sequencing analysis found a novel missense variant Ile74Asn (c.221T > A) in heterozygous state on an M3 allele (Glu400Asp) in the exon 2 of the SERPINA-1gene, probably leading to a dysfunctional protein. This mutation has never been previously identified, and it is interesting to note the association with bronchiectasis in the absence of emphysema.

Entities:  

Keywords:  Alpha-1-antitrypsin deficiency; Augmentation therapy; Bronchiectasis; New SERPINA1 mutations

Mesh:

Substances:

Year:  2017        PMID: 28668972     DOI: 10.1007/s00408-017-0033-2

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  17 in total

1.  Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countries.

Authors:  I Blanco; F J de Serres; E Fernandez-Bustillo; B Lara; M Miravitlles
Journal:  Eur Respir J       Date:  2006-01       Impact factor: 16.671

Review 2.  Clinical practice. Alpha1-antitrypsin deficiency.

Authors:  Edwin K Silverman; Robert A Sandhaus
Journal:  N Engl J Med       Date:  2009-06-25       Impact factor: 91.245

3.  A null deficiency allele of alpha 1-antitrypsin, QOludwigshafen, with altered tertiary structure.

Authors:  G C Frazier; M A Siewertsen; M H Hofker; M G Brubacher; D W Cox
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

4.  The effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiency.

Authors:  Robert A Stockley; Darren L Bayley; Ipek Unsal; Lee J Dowson
Journal:  Am J Respir Crit Care Med       Date:  2002-06-01       Impact factor: 21.405

5.  Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency.

Authors:  David G Parr; Peter G Guest; John H Reynolds; Lee J Dowson; Robert A Stockley
Journal:  Am J Respir Crit Care Med       Date:  2007-09-13       Impact factor: 21.405

6.  European screening for alpha1 -antitrypsin deficiency in subjects with lung disease.

Authors:  Timm Greulich; Alexander Averyanov; Ludmila Borsa; Eva Rozborilová; Dalius Vaicius; Tamás Major; Valentyna Chopyak; Voicu Tudorache; Tatyana Konstantinova; Sandra Camprubí
Journal:  Clin Respir J       Date:  2015-06-11       Impact factor: 2.570

7.  Therapeutic efficacy of α-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry.

Authors:  Robert A Stockley; David G Parr; Eeva Piitulainen; Jan Stolk; Berend C Stoel; Asger Dirksen
Journal:  Respir Res       Date:  2010-10-05

8.  Etiology of Non-Cystic Fibrosis Bronchiectasis in Adults and Its Correlation to Disease Severity.

Authors:  Sara Lonni; James D Chalmers; Pieter C Goeminne; Melissa J McDonnell; Katerina Dimakou; Anthony De Soyza; Eva Polverino; Charlotte Van de Kerkhove; Robert Rutherford; John Davison; Edmundo Rosales; Alberto Pesci; Marcos I Restrepo; Antoni Torres; Stefano Aliberti
Journal:  Ann Am Thorac Soc       Date:  2015-12

9.  Why do some adults with PiMZ α1-antitrypsin develop bronchiectasis? [corrected]

Authors:  Nupur Aggarwal; Beatriz Martinez Delgado; Sandeep Salipalli; Nerea Matamala; Jessica Rademacher; Nicolaus Schwerk; Tobias Welte; Sabina Janciauskiene; Felix C Ringshausen
Journal:  ERJ Open Res       Date:  2016-06-06

10.  Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003 - 2015.

Authors:  Timm Greulich; Christoph Nell; Christian Herr; Claus Vogelmeier; Viktor Kotke; Stefan Wiedmann; Marion Wencker; Robert Bals; Andreas Rembert Koczulla
Journal:  Orphanet J Rare Dis       Date:  2016-06-10       Impact factor: 4.123

View more
  4 in total

1.  Feasibility of a genotyping system for the diagnosis of alpha1 antitrypsin deficiency: a multinational cross-sectional analysis.

Authors:  José Luis Lopez-Campos; Lourdes Osaba; Karen Czischke; José R Jardim; Mariano Fernandez Acquier; Abraham Ali; Hakan Günen; Noelia Rapun; Estrella Drobnic; Marc Miravitlles
Journal:  Respir Res       Date:  2022-06-10

2.  Liver biopsy derived induced pluripotent stem cells provide unlimited supply for the generation of hepatocyte-like cells.

Authors:  Diego Calabrese; Guglielmo Roma; Sebastian Bergling; Walter Carbone; Valentina Mele; Sandro Nuciforo; Isabel Fofana; Benedetta Campana; Dagmara Szkolnicka; David C Hay; Jan Tchorz; Tewis Bouwmeester; Stefan Wieland; Markus H Heim
Journal:  PLoS One       Date:  2019-08-29       Impact factor: 3.240

3.  Description of a new rare alpha-1 antitrypsin mutation in Naples (Italy): PI*M S-Napoli.

Authors:  Marco Mosella; Mariasofia Accardo; Antonio Molino; Mauro Maniscalco; Alessandro Sanduzzi Zamparelli
Journal:  Ann Thorac Med       Date:  2018 Jan-Mar       Impact factor: 2.219

4.  Alpha-1-Antitrypsin Deficiency and Bronchiectasis: A Concomitance or a Real Association?

Authors:  Alessandro Sanduzzi; Emanuele Ciasullo; Ludovica Capitelli; Stefano Sanduzzi Zamparelli; Marialuisa Bocchino
Journal:  Int J Environ Res Public Health       Date:  2020-03-29       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.